M P8 (Pantoprazole Sodium Delayed Release 20 mg)
Pill with imprint M P8 is Yellow, Elliptical / Oval and has been identified as Pantoprazole Sodium Delayed Release 20 mg. It is supplied by Matrix Laboratories Limited.
Pantoprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; gerd; gastritis/duodenitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M P8
Pantoprazole Sodium Delayed Release
- Imprint
- M P8
- Strength
- 20 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Matrix Laboratories Limited
- National Drug Code (NDC)
- 00378-6688
- Inactive Ingredients
-
ferrosoferric oxide,
calcium stearate,
mannitol,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
propylene glycol,
sodium carbonate,
shellac,
titanium dioxide,
triethyl citrate,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related Images for "M P8"
More about pantoprazole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 288 Reviews
- Drug class: proton pump inhibitors
- FDA Alerts (4)
Consumer resources
- Patient Information
- Pantoprazole (Advanced Reading)
- Pantoprazole Intravenous (Advanced Reading)
- Pantoprazole Delayed-Release Tablets
- Pantoprazole Delayed-Release Granules
- Pantoprazole Injection
- Other brands
- Protonix, Protonix IV
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.